About

CEO and Cofounder Malcolm Kendall has over 28 years of operational management, entrepreneurial, venture capital investment and leadership experience, the majority of which has been focused on company creation and building value in technology and biotechnology companies. Before founding Microbiome Insights, he was the co-founder and CEO of Indel Therapeutics Inc., a Vancouver-based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. Prior to this, Malcolm was an investment professional with life science focused venture capital firms MDS Capital (now Lumira Capital), BioVista Capital (now Hatteras Venture Partners) and Intersouth Partners. Before entering business, he served in the U.S. Army where he honed his leadership skills as an Infantry and Special Forces officer. Malcolm has been an advisor and board member to numerous companies and organizations and is currently a member of the board of directors of Semios BIO Technologies, a mentor for the entrepreneurship@UBC program and an adjunct professor at the MBA MOT program at Simon Fraser University. He received his undergraduate degree from Washington and Lee University and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina.

Entries by Malcolm Kendall

Statement from Microbiome Insights on Racism

Message on Covid-19 from Microbiome Insights

PRESS RELEASE: Microbiome Insights launches new shallow shotgun sequencing service

VANCOUVER, CANADA – October 25, 2019 Accurate information on microbiome function and high-resolution taxonomy is very valuable for microbiome studies—but the high cost of shotgun metagenomic sequencing can be a barrier. Now Microbiome Insights, a global leader in microbiome analysis, gives clients...

Read more

PRESS RELEASE: New Study Finds Key Factors That Shape the Skin Microbiome, Including Age and Lifestyle Choices

A skin microbiome study undertaken by Amway in collaboration with Microbiome Insights has now been published in the scientific journal mBio. The study, which enrolled 495 people (aged 9 to 78) who provided over 2500 skin swab samples, was the largest survey of the healthy human skin microbiome ever...

Read more

Microbiome Insights to mark opening of new lab space with champagne reception and microbiome poster competition

Microbiome Insights, Inc. is planning to move operations into a new laboratory space in UBC's Pharmaceutical Sciences building -- and to mark the occasion, they will host a champagne reception with a poster competition open to local microbiome researchers.

Read more

Microbiome Insights Establishes Scientific Advisory Board

September 23, 2015 – Microbiome Insights, Inc. is pleased to announce today the formation of its inaugural Scientific Advisory Board (SAB). The board is comprised of leaders in the field whose work has led to significant breakthroughs in both basic and clinical understandings of the microbiome.

Read more

Life sciences industry leaders form Microbiome Insights’ inaugural board of directors

MAY 30, 2015 -- Microbiome Insights, Inc. is pleased to announce the members of its inaugural Board of Directors (BOD). The members bring with them a wealth of knowledge from the global life sciences industry. Each one has achieved success in academic and/or industry roles and has contributed to...

Read more

Microbiome Insights Officially Incorporates

February 12, 2015 – Microbiome Insights, Inc. announced its official incorporation today as a company providing end-to-end services in microbiome analysis. These services, which include experimental design, sample testing, and bioinformatic analysis, are aimed at researchers in both academia and...

Read more